NYSE Euronext today announced the listing on NYSE Alternext in Paris of Global Bioenergies, a company specialized in bioprocesses that convert renewable resources into hydrocarbons.
Founded in 2008, Global Bioenergies is developing a unique process to produce isobutene biologically from renewable resources. Isobutene, a hydrocarbon currently obtained exclusively from fossil oil, is one of the key building blocks of the petrochemical industry. It can be used to produce each of the three main fuels - gasoline, diesel and kerosene - as well as a wide range of other materials (synthetic rubber, organic glass and plastics). Global Bioenergies is a French company based in Evry, south of Paris, and employs a staff of around 20 that is primarily involved in R&D.
Global Bioenergies (ticker code: ALGBE) was listed through admission to trading of 1,246,500 existing shares and 333,675 new shares and additional new shares issued under a Global Offering, including full exercise of the extension clause and over-allotment option. The Global Offering raised a total of €6.6 million, including full exercise of the extension clause and over-allotment option.
The admission and issue price of Global Bioenergies shares was set at €19.85. Market capitalization stood at €31.4 million on the day of listing.